Dynavax Technologies Corporation (NASDAQ:DVAX) announced that HEPLISAV-B™ (Hepatitis B Vaccine) for the prevention of hepatitis B in adults is now available for prescription in the …
Cowen believes Dynavax has an asset on its hands that fulfills a valuable unmet need.
Dynavax Technologies Corporation (NASDAQ:DVAX) has won U.S.
Dynavax Technologies Corporation (NASDAQ:DVAX) announced initiation of dosing in patients with non-small cell lung cancer (NSCLC). This multi-center, open label trial is designed …